Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-15

Clinical Trial Update: Progesterone Primed Protocol Versus GnRH Antagonist in With PCO Undergoing ICSI [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update comparing a progesterone-primed protocol with a GnRH antagonist in women with polycystic ovary syndrome undergoing ICSI, completed at Beni…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • GnRH antagonist
  • PROGESTERONE (Progesterone)

Snippet

Sponsor: Beni-Suef University | Conditions: IVF, PCO | Phase 2, Phase 3 | Status: COMPLETED